You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Letters Androgen Suppression Plus Radiation Therapy for Prostate Cancer—Reply
Anthony V. D’Amico; Marian Loffredo; Judith Manola; Alyssa DellaCroce; Andrew A. Renshaw; Philip W. Kantoff
JAMA 2004; 292: 2085.
[Extract][Full text][PDF]
Reviews Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
Thomas G. Roberts Jr; Bernardo H. Goulart; Lee Squitieri; Sarah C. Stallings; Elkan F. Halpern; Bruce A. Chabner; G. Scott Gazelle; Stan N. Finkelstein; Jeffrey W. Clark
JAMA 2004; 292: 2130-2140.
[Abstract][Full text][PDF]
Editorials Risks and Benefits of Phase 1 Clinical Trials Evaluating New Anticancer Agents: A Case for More Innovation
Letters Tenofovir, Equivalence, and Noninferiority—Reply
Joel E. Gallant; Schlomo Staszewski; Anton L. Pozniak; Edwin DeJesus; Jamal M. A. H. Suleiman; Biao Lu; John J. Toole; Andrew K. Cheng
JAMA 2004; 292: 1951-a-1952-a.
[Extract][Full text][PDF]
Letters Tenofovir, Equivalence, and Noninferiority
Preliminary Communications Repetitive Bilateral Arm Training and Motor Cortex Activation in Chronic Stroke: A Randomized Controlled Trial
Andreas R. Luft; Sandy McCombe-Waller; Jill Whitall; Larry W. Forrester; Richard Macko; John D. Sorkin; Jörg B. Schulz; Andrew P. Goldberg; Daniel F. Hanley
JAMA 2004; 292: 1853-1861.
[Abstract][Full text][PDF]
